102 related articles for article (PubMed ID: 30076987)
1. Heptanoate is neuroprotective in vitro but triheptanoin post-treatment did not protect against middle cerebral artery occlusion in rats.
Tan KN; Hood R; Warren K; Pepperall D; Carrasco-Pozo C; Manzanero S; Borges K; Spratt NJ
Neurosci Lett; 2018 Sep; 683():207-214. PubMed ID: 30076987
[TBL] [Abstract][Full Text] [Related]
2. Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration.
Tan KN; Simmons D; Carrasco-Pozo C; Borges K
J Neurochem; 2018 Feb; 144(4):431-442. PubMed ID: 29222946
[TBL] [Abstract][Full Text] [Related]
3. Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin.
Schwarzkopf TM; Koch K; Klein J
Neuroscience; 2015 Aug; 300():201-9. PubMed ID: 25982559
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats.
Ip FC; Zhao YM; Chan KW; Cheng EY; Tong EP; Chandrashekar O; Fu GM; Zhao ZZ; Ip NY
BMC Complement Altern Med; 2016 Nov; 16(1):437. PubMed ID: 27814708
[TBL] [Abstract][Full Text] [Related]
5. The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders.
Lee SK; Gupta M; Shi J; McKeever K
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1325-1334. PubMed ID: 33789001
[TBL] [Abstract][Full Text] [Related]
6. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
Pengyue Z; Tao G; Hongyun H; Liqiang Y; Yihao D
Biomed Pharmacother; 2017 Jun; 90():69-76. PubMed ID: 28343073
[TBL] [Abstract][Full Text] [Related]
7. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.
Li DJ; Li YH; Yuan HB; Qu LF; Wang P
Metabolism; 2017 Mar; 68():31-42. PubMed ID: 28183451
[TBL] [Abstract][Full Text] [Related]
8. Isoquercetin attenuates oxidative stress and neuronal apoptosis after ischemia/reperfusion injury via Nrf2-mediated inhibition of the NOX4/ROS/NF-κB pathway.
Dai Y; Zhang H; Zhang J; Yan M
Chem Biol Interact; 2018 Mar; 284():32-40. PubMed ID: 29454613
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
Gupta S; Sharma U; Jagannathan NR; Gupta YK
Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
[TBL] [Abstract][Full Text] [Related]
11. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats.
Kinman RP; Kasumov T; Jobbins KA; Thomas KR; Adams JE; Brunengraber LN; Kutz G; Brewer WU; Roe CR; Brunengraber H
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E860-6. PubMed ID: 16705058
[TBL] [Abstract][Full Text] [Related]
12. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
[TBL] [Abstract][Full Text] [Related]
13. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats.
Gupta S; Gupta YK
J Ethnopharmacol; 2017 Feb; 197():118-127. PubMed ID: 27452658
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia.
Zhang F; Wang S; Signore AP; Chen J
Stroke; 2007 Aug; 38(8):2329-36. PubMed ID: 17600230
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of gallic acid against hypoxia/reoxygenation-induced mitochondrial dysfunctions in vitro and cerebral ischemia/reperfusion injury in vivo.
Sun J; Li YZ; Ding YH; Wang J; Geng J; Yang H; Ren J; Tang JY; Gao J
Brain Res; 2014 Nov; 1589():126-39. PubMed ID: 25251593
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats.
Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M
Neuroscience; 2017 Mar; 344():305-325. PubMed ID: 28057538
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective role of fucoxanthin against cerebral ischemic/reperfusion injury through activation of Nrf2/HO-1 signaling.
Hu L; Chen W; Tian F; Yuan C; Wang H; Yue H
Biomed Pharmacother; 2018 Oct; 106():1484-1489. PubMed ID: 30119223
[TBL] [Abstract][Full Text] [Related]
20. Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.
Marin-Valencia I; Good LB; Ma Q; Malloy CR; Pascual JM
J Cereb Blood Flow Metab; 2013 Feb; 33(2):175-82. PubMed ID: 23072752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
